RecruitingNCT03758521
Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency
Studying Succinic semialdehyde dehydrogenase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Phillip L Pearl, MDBoston Children's Hospital/Harvard Medical School
- Intervention
- Transcranial magnetic stimulation (TMS)(device)
- Enrollment
- 55 target
- Eligibility
- All sexes
- Timeline
- 2019 – 2029
Study locations (4)
- Boston Children's Hospital, Boston, Massachusetts, United States
- University Children's Hospital, Heidelberg, Heidelberg, Germany
- Sant Joan de Deu Hospital Barcelona, Barcelona, Spain
- Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom
Collaborators
Washington State University · University of South Florida · University Hospital Heidelberg · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03758521 on ClinicalTrials.gov